4C Mortality Score for COVID-19
ورودیهای بالینی بیمار
حداقل ۰ — حداکثر ۱۲۰ • واحد: years
حداقل ۰ — حداکثر ۲۰ • واحد: comorbidities
حداقل ۵ — حداکثر ۶۰ • واحد: breaths/min
حداقل ۵۰ — حداکثر ۱۰۰ • واحد: %
حداقل ۳ — حداکثر ۱۵ • واحد: points
حداقل ۰.۱ — حداکثر ۳۰۰ • واحد: variable
حداقل ۰ — حداکثر ۱۰۰۰ • واحد: mg/L
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low Risk0–3
- Intermediate Risk4–8
- High Risk9–14
- Very High Risk15–21
The 4C Mortality Score for COVID-19 calculates predicting in-hospital mortality in patients admitted with COVID-19. Key inputs include age. Scores guide administering empiric broad-spectrum antimicrobial regimens, infectious source control, and isolation protocols. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Predicts in-hospital mortality in patients admitted with COVID-19
Clinical Indication
The 4C Mortality Score for COVID-19 is indicated for bedside clinical practice to support Predicts in-hospital mortality in patients admitted with COVID-19. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with suspected sepsis, meningitis, pneumonia, COVID-19, opportunistic infections, or fever of unknown origin. Clinical application is indicated across Infectious disease services, septic shock bays, febrile illness clinics, and isolation units.
Limitations & Contraindications
Timely administration of empiric antibiotic therapy in suspected septic shock must never be delayed for score tabulation.
Clinical Pearls & Action Plan
Blood and site-specific microbiological cultures should be secured prior to administering broad-spectrum antimicrobials.
Points = Age (0-7) + Sex (0-1) + Comorbidities (0-2) + RR (0-2) + SpO2 (0-2) + Glasgow (0-2) + Urea (0-3) + CRP (0-2)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| age | integer | Yes | Patient's age in years(years) |
| sex | string | Yes | Patient's sex |
| comorbidities | integer | Yes | Number of comorbidities (chronic heart disease, chronic lung disease except asthma, CKD with GFR ≤30, mild-severe liver disease, dementia, chronic neurological diseases, connective tissue diseases, diabetes, HIV/AIDS, malignancy)(comorbidities) |
| respiratory_rate | integer | Yes | Respiratory rate(breaths/min) |
| oxygen_saturation | float | Yes | Peripheral oxygen saturation(%) |
| glasgow_coma_scale | integer | Yes | Glasgow Coma Scale(points) |
| urea_unit | string | Yes | Urea measurement unit |
| urea_value | float | Yes | Serum urea value(variable) |
| crp | float | Yes | C-reactive protein(mg/L) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–3 | Low Risk | Low mortality risk |
| 4–8 | Intermediate Risk | Intermediate mortality risk |
| 9–14 | High Risk | High mortality risk |
| 15–21 | Very High Risk | Very high mortality risk |
Evidence-Based References (EBM)
- Knight SR, Ho A, Pius R, et al. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score. BMJ. 2020;370:m3339.
- Gupta RK, Marks M, Samuels THA, et al. Systematic evaluation and external validation of 22 prognostic models among hospitalised adults with COVID-19: an observational cohort study. Eur Respir J. 2020;56(6):2003498.